National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs

NCCN 12th Annual Congress:
Hematologic Malignancies™

DATES > Friday, October 6 – Saturday, October 7, 2017            LEARN MORE>

LOCATION > Hilton San Francisco Union Square • San Francisco, California

Additional Programs:
Save the Date!
NCCN Global Academy > Friday, October 6, 2017          

New Program for Nurses!
NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ > Friday, October 6, 2017  


Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.


Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center



Friday, October 6, 2017

4:30 – 6:00 PM

Registration, Exhibits, and Refreshments

6:00 – 8:35 PM

Educational Sessions

Saturday, October 7, 2017

6:30 AM  

Registration Opens

7:00 – 8:00 AM

Registration, Exhibits, and Breakfast

8:00 AM – 5:00 PM

Educational Sessions

*Subject to change.

Recorded Presentations
Earn up to 8.75 credits with recorded presentations from the NCCN 11th Annual Congress: Hematologic Malignancies™ that took place September 30 - October 1, 2016 in New York, NY.

Recorded Lunch Symposium – The Future of Targeted Therapies for Acute Myeloid Leukemia
Earn .75 credit! This activity is designed to address the unprecedented recent and ongoing advances in AML research and anticipated changes in the AML therapeutic landscape resulting from the development of many innovative therapies, several of which are in late stages of clinical trials.

For a complete list of available recordings from the NCCN 11th Annual Congress: Hematologic Malignancies, please visit

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.